Ginkgo Bioworks (DNA) said Tuesday it has formed a partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign to develop new oral health treatments.
The company said it will use its EncapS technology for ultra-high-throughput screening to identify and evaluate phage-based interventions targeting specific bacteria in the oral microbiome.
Ginkgo Bioworks' shares were 2% lower in recent trading.
Price: 7.63, Change: -0.14, Percent Change: -1.80